| abstract |
The present invention relates to a tris salt of 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione of Formula (A): (See formula (A)) the methods of corresponding manufacturing, the pharmaceutical formulations containing them and the uses of the aforementioned compounds in therapy, particularly in the treatment of diseases where the sub-activation of the HM74A receptor contributes to the disease or where the activation of the receptor can be beneficial. |